The treatment of Heart Health & Prostatitis with vitamins

Heart Health and Prostatitis: Mitamins custom make quality formulas for the treatment of Heart Health & Prostatitis with vitamins. A Heart Health & Prostatitis formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Heart Health and Prostatitis

  • Amount Per Serving
    % DV
    Vitamin C
    100
    mg
    167%
    Thiamin
    50
    mg
    3333%
    Magnesium
    25
    mg
    6%
    Zinc
    10
    mg
    67%
    CoQ-10
    30
    mg
    *
    Omega - 3 Fatty Acids
    100
    mg
    *
    Garlic Extract
    50
    mg
    *
    Hawthorn Extract
    100
    mg
    *
  • Amount Per Serving
    % DV
    Nettle Extract
    50
    mg
    *
    Quercetin
    50
    mg
    *
    Saw Palmetto Extract
    40
    mg
    *
    L-Carnitine
    100
    mg
    *
    Turmeric Extract
    50
    mg
    *
    Pygeum Extract
    40
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Heart Health and Prostatitis
Monthly Cost: $27.56
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Heart Health and Prostatitis Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
ERBITUX(R) Meets Primary Endpoint Of Increasing Survival In Phase III Lung Cancer Study
ImClone Systems Incorporated (Nasdaq: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) today announced that a Phase III study of ERBITUX(R) (Cetuximab) in combination with platinum-based chemotherapy (vinorelbine plus cisplatin) met its primary endpoint of increasing overall survival compared with chemotherapy alone in patients with advanced non-small cell lung cancer (NSCLC).
Cryptopharma Cystic Fibrosis Inflammation Drug To Be Commercialised - Targeting Inflammation Via Novel Mode Of Action
Melbourne based biotechnology company Cryptopharma Pty Ltd announced that its inflammation drug candidate, CP-92, has been chosen as a lead and will be advanced into development after very positive results from laboratory testing. The product is an Australian innovation and has shown high levels of activity in animal models of inflammatory respiratory disease. It will initially be developed for the treatment of acute inflammation associated with cystic fibrosis.
This information concerning the support of Heart Health and Prostatitis treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Heart & Vascular Health  Heart Health  Heart Health and Prostatitis
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments